News

Stay In The Know

Get regular insights, opinions and updates on the Chemistree and the industry.

No spam – Unsubscribe anytime

Chemistree To Invest Up To $200,000 In Pure-play Renewable Energy -update On Debt Restructuring

Vancouver, British Columbia, December 2, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a Subscription Agreement with Philippine Metals Inc. (“PHI”) to invest up to $200,000 in Subscription Receipts.  PHI, a TSX Venture Exchange listed issuer, is currently

Read More »

Chemistree Seeks Approval To Restructure Convertible Debt

Vancouver, British Columbia, November 5, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) announces that it has filed Notice of an Extraordinary Meeting of Debentureholders to be held November 30, 2021 (the “Meeting”).  At the Meeting, debentureholders (the “Debentureholders”) will be asked to consider and, if deemed appropriate,

Read More »

Chemistree Investee Immunoflex Completes Clinical Study And Submits Us And International Patent Applications

Vancouver, British Columbia, July 13th, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company Immunoflex Therapeutics Inc. (“ImmunoFlex”™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The exploratory trial was the

Read More »

Why New Jersey Is An Interesting Market For Chemistree

The American Cannabis industry is growing fast presenting numerous opportunities for cannabis companies. Medical marijuana is already legal in over 30 states and so far 10 states have legalized recreational use with around four in the process to legalize adult use. New Jersey is among the four states on the path of legalizing recreational use

Read More »

Industry Veteran Sheldon Aberman opening up new US opportunities for Chemistree

Chemistree Technology Inc. (OTC: CHMJF) is ready to seize on the wide variety of opportunities that are presenting themselves due to the rollercoaster year in the North American Cannabis sector. The Team at Chemistree is able to utilize these downturns to quickly deploy it’s capital and management expertise to make smart investments or acquisitions of

Read More »

Chemistree Completes Investment In New Jersey Cannabis Applicant – ACS

Vancouver, British Columbia, July 22, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that through a wholly owned U.S. subsidiary, the Company has finalized its investment into Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical vertically integrated applicant, previously announced as a

Read More »

HOW CHEMISTREE TECHNOLOGY ESTABLISHED BEACHHEAD ON U.S. EAST COAST

Started with the vision to create a broad-based company with full spectrum participation in the cannabis sector, Chemistree Technology Inc. (CA: CHM – $0.40 & US: CHMJF – $0.27 & GER: CM1 – €0.26) has rapidly advanced through its early growth phase with an ambitious investment plan. Although the Company is headquartered in Vancouver, Canada, the appeal

Read More »

Chemistree Announces Resignation of Non-Executive Chairman

VANCOUVER, June 14, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), announces that Non-executive Chairman of the board, Justin Chorbajian has tendered his resignation. Company president Karl Kottmeier commented, “On behalf of the board I’d like to thank Justin for his contributions to the Company over the past twenty-two months, and we wish him well

Read More »

CHEMISTREE COMMENTS ON RECENT PROMOTIONAL ACTIVITY AT REQUEST OF OTC MARKETS

VANCOUVER, June 13, 2019 /CNW/ – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), has been requested by OTC Markets Group to comment on recent promotional activity. The Company first became aware of certain promotional third-party newsletter activities through a notification by OTC Markets on June 11, 2019. The Company takes its investor relations

Read More »

CHEMISTREE PARTNER, ACS, TO FILE NEW JERSEY APPLICATION UNDER NEW DOH MANDATE

Vancouver, British Columbia, June 10, 2019 – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that its partner Applied Cannabis Sciences of New Jersey (“ACS”), is readying an Application under the new Request for Applications (RFA) program announced by the Department of Health on June 3, 2019.

Read More »
Scroll to Top